Serum S100B Predicts a Malignant Course of Infarction in Patients With Acute Middle Cerebral Artery Occlusion

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Stroke

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000138730.03264.acPMID 15297628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of malignant course in MCA infarction by PET and microdialysis.

  2003influential reference
• Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion-Weighted Magnetic Resonance Imaging

  2003cited by this paper
• S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion

  2003cited by this paper
• Clinical outcome and neuropsychological deficits after right decompressive hemicraniectomy in MCA infarction

  2002cited by this paper
• Prognosis of patients after hemicraniectomy in malignant middle cerebral artery infarction

  2002cited by this paper
• Aggressive Decompressive Surgery in Patients with Massive Hemispheric Embolic Cerebral Infarction Associated with Severe Brain Swelling

  2001cited by this paper
• Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging

  2000cited by this paper
• Mortality of space-occupying (‘malignant’) middle cerebral artery infarction under conservative intensive care

  1998cited by this paper
• Early hemicraniectomy in patients with complete middle cerebral artery infarction.

  1998cited by this paper
• 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema.

  1998cited by this paper
• S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

  1997cited by this paper
• S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

  1997cited by this paper
• Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.

  1997cited by this paper
• Mass effect and death from severe acute stroke

  1997cited by this paper
• 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

  1996cited by this paper
• 'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs

  1996cited by this paper

• Emerging biomarkers in ischemic stroke

  2025cites this paper
• Clinical, Imaging, and Serum Biomarker Predictors of Malignant Cerebral Infarction

  2025cites this paper
• Increased middle cerebral artery velocity predicts malignant media infarction after endovascular stroke thrombectomy

  2025cites this paper
• Blood and cerebrospinal fluid biomarkers in disorders of consciousness.

  2025cites this paper
• Brain white matter damage biomarkers.

  2025cites this paper
• Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic Stroke

  2024cites this paper
• The serum biomarkers NSE and S100B predict intracranial complications and in-hospital survival in patients undergoing veno-venous ECMO

  2024cites this paper
• Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein

  2024cites this paper
• Blood-brain barrier biomarkers.

  2024cites this paper
• Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis

  2024cites this paper
• Recent Advance of S100B Proteins in Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.

  2024cites this paper
• Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury

  2023cites this paper
• Malignant middle cerebral artery infarction during early versus late endovascular treatment in acute ischemic stroke.

  2023cites this paper
• Secondary neurodegeneration following Stroke: what can blood biomarkers tell us?

  2023cites this paper
• The clinical value of serum xanthine oxidase levels in patients with acute ischemic stroke

  2023cites this paper
• Use of biomarkers for predicting a malignant course in acute ischemic stroke: an observational case–control study

  2023cites this paper
• Surgery for Malignant Acute Ischemic Stroke: A Narrative Review of the Knowns and Unknowns

  2023cites this paper
• Biomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons

  2022cites this paper
• Fluid biomarkers in stroke: From animal models to clinical care

  2022cites this paper
• A nomogram for predicting malignant cerebral artery infarction in the modern thrombectomy era

  2022cites this paper
• Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke

  2022cites this paper
• Malignant infarction after endovascular treatment: Incidence and prediction

  2021cites this paper
• Future Application: Prognosis Determination

  2021cites this paper
• Acute Stroke Biomarkers: Are We There Yet?

  2021cites this paper
• Role of S100β Glial Protein as a Serological Marker for Analysis of Acute Ischemic Stroke

  2021cites this paper
• Development of Biomarkers and Point-of-Care Tests for Cerebrovascular Pathology: A Marriage of Chemistry, Biology, and Medicine

  2021cites this paper
• Blood Biomarkers in the Diagnosis of Acute Stroke

  2021cites this paper
• Role of S100B Serum Concentration as a Surrogate Outcome Parameter After Mechanical Thrombectomy

  2021cites this paper
• Serum S100β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke.

  2020influential citation
• Prediction of Malignant Acute Middle Cerebral Artery Infarction via Computed Tomography Radiomics

  2020cites this paper
• Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events

  2020cites this paper
• High serum S-100B protein levels within the first 36 hours of acute ischemic stroke predicts high NIHSS scores

  2020influential citation
• Predictors of malignant cerebral edema in cerebral artery infarction: A meta-analysis.

  2019cites this paper
• Blood Biomarkers for Stroke Diagnosis and Management

  2019cites this paper
• Cerebral Edema Associated With Large Hemispheric Infarction.

  2019cites this paper
• Computed tomography perfusion in detecting malignant middle cerebral artery infarct

  2019cites this paper
• Serum MicroRNA-Based Risk Prediction for Stroke.

  2019cites this paper
• Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application

  2019cites this paper
• Neuroprotective Role of Dexmedetomidine in Epilepsy Surgery

  2019cites this paper
• Biomarkers of Delirium Duration and Delirium Severity in the ICU*

  2019cites this paper
• [S100B protein in the blood of children with autism spectrum disorders].

  2019cites this paper
• Serum S 100 β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke

  2019influential citation
• S100ß, Matrix Metalloproteinase-9, D-dimer, and Heat Shock Protein 70 Are Serologic Biomarkers of Acute Cerebral Infarction in a Mouse Model of Transient MCA Occlusion

  2018cites this paper
• Ursolic Acid Ameliorates Inflammation in Cerebral Ischemia and Reperfusion Injury Possibly via High Mobility Group Box 1/Toll-Like Receptor 4/NFκB Pathway

  2018cites this paper
• The potential role of blood biomarkers in patients with ischemic stroke

  2018cites this paper
• COULD BE CONSIDERED SERUM ANTI-S-100 AUTOANTIBODIES A BIOMARKER IN PATIENTS WITH ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE?

  2018cites this paper
• The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome

  2018cites this paper
• Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research

  2018cites this paper
• Efficacy of SMTP‐7, a small‐molecule anti‐inflammatory thrombolytic, in embolic stroke in monkeys

  2018cites this paper
• Role of S-100β in stroke

  2018cites this paper
• The Role of Glycerol-Containing Drugs in Cerebral Microdialysis: A Retrospective Study on the Effects of Intravenously Administered Glycerol

  2018cites this paper
• What to Look for on Post-stroke Neuroimaging.

  2018cites this paper
• Early Prediction of Malignant Brain Edema After Ischemic Stroke: A Systematic Review and Meta-Analysis

  2018cites this paper
• Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke

  2017cites this paper
• Prospects of modeling poststroke epileptogenesis

  2017cites this paper
• S100 B: A new concept in neurocritical care

  2017cites this paper
• The roles of S 100 B in neuronal survival

  2016cites this paper
• A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury

  2016cites this paper
• Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care.

  2016cites this paper
• Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases.

  2016cites this paper
• Prediction of Outcome in Diabetic Acute Ischemic Stroke Patients: A Hospital-Based Pilot Study Report

  2016cites this paper
• Correlation of serum S-100 protein level with involvement of territory and size of lesion in acute ischemic stroke

  2016cites this paper
• Malignant hemispheric infarction of the middle cerebral artery. Diagnostic considerations and treatment options.

  2016cites this paper
• Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

  2016cites this paper
• Infarto hemisférico maligno de la arteria cerebral media. Consideraciones diagnósticas y opciones terapéuticas

  2016cites this paper
• Blood biomarkers in the early stage of cerebral ischemia.

  2016cites this paper
• Glial biomarkers in human central nervous system disease

  2016cites this paper
• S100B raises the alert in subarachnoid hemorrhage

  2016cites this paper
• Malignant Ischemic Infarction

  2016cites this paper
• Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions

  2015cites this paper
• Biomarcadores séricos e prognóstico no acidente vascular cerebral

  2015cites this paper
• Serum S100B levels may be associated with cerebral infarction: a meta-analysis.

  2015cites this paper
• Research for biomarkers in ischemic stroke

  2015cites this paper
• Neurosurgery Neurosurgery in Ischemic Stroke

  2015cites this paper
• Hemicraniectomy for malignant middle cerebral artery territory infarction: an updated review.

  2015cites this paper
• Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A systematic review and meta-analysis.

  2015cites this paper
• To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication

  2015cites this paper
• On Biomarkers in Traumatic Brain Injury THESIS FOR DOCTORAL DEGREE ( Ph . D . ) By

  2015cites this paper
• Evaluation of Peptide-Based Approach for Estimation of Nse and S-100ββ towards the Development of a Cost-Effective Test for Prognosis of AIS Patients

  2015cites this paper
• Inflammatory Biomarkers in Patients with Acute Brain Injuries

  2014cites this paper
• Análisis de marcadores inflamatorios y polimorfismos en genes de moléculas proinflamatorias en la isquemia cerebral: relación con la gravedad y situación funcional tras el ictus

  2014cites this paper
• Serum Biomarkers of Brain Injury to Classify Outcome After Pediatric Cardiac Arrest*

  2014cites this paper
• Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2014cites this paper
• Acute Supratentorial Ischemic Stroke: When Surgery Is Mandatory

  2014cites this paper
• Monitoring Biomarkers of Cellular Injury and Death in Acute Brain Injury

  2014cites this paper
• Low Alberta Stroke Program Early CT Score (ASPECTS) Associated with Malignant Middle Cerebral Artery Infarction

  2014cites this paper
• Biomarkers and acute brain injuries: interest and limits

  2014cites this paper
• Stroke Association Swelling : A Statement for Healthcare Professionals From the American Heart Recommendations for the Management of Cerebral and Cerebellar Infarction

  2014cites this paper
• Assessment of S100β Biomarker in Acute Ischemic Cerebrovascular Stroke Patients with Hypertension

  2014cites this paper
• Molecular Biomarkers in Neurocritical Care: The Next Frontier

  2014cites this paper
• Treatment of Malignant Brain Edema and Increased Intracranial Pressure After Stroke

  2014cites this paper
• S100B and delirium in the geriatric acute care setting

  2014cites this paper
• Neurosurgery in Ischemic Stroke

  2014cites this paper
• Association/American Stroke Association Swelling: A Statement for Healthcare Professionals From the American Heart Recommendations for the Management of Cerebral and Cerebellar Infarction With

  2014cites this paper
• A surgical model of middle cerebral artery occlusive stroke in the sheep.

  2014cites this paper
• Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis

  2013cites this paper
• On PUMP Versus Off PUMP Coronary Bypass Grafting Post-Operative Clinical and Laboratory Focus on Neurological Outcome

  2013cites this paper
• Ischemic stroke biomarkers in blood.

  2013cites this paper
• Electroacupuncture reduces hemiplegia following acute middle cerebral artery infarction with alteration of serum NSE, S-100B and endothelin.

  2013cites this paper
• Mecanismos e Funções da Proteína S100B Durante a Hipóxia

  2013cites this paper